Quick Answer
HAEMONETICS CORP reported Long-Term Debt of $921.23 million for fiscal year 2025.
HAEMONETICS CORP Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $921.23M | +15.5% |
| 2024 | $797.56M | +5.8% |
| 2023 | $754.10M | +34.8% |
| 2022 | $559.44M | -19.0% |
| 2021 | $690.59M | +126.0% |
| 2020 | $305.51M | -5.3% |
| 2019 | $322.45M | +442.6% |
| 2018 | $59.42M | -76.6% |
| 2017 | $253.62M | -30.4% |
| 2016 | $364.53M | -10.3% |
| 2015 | $406.37M | +3.7% |
| 2014 | $392.06M | -14.2% |
| 2013 | $456.94M | +15782.7% |
| 2012 | $2.88M | -27.5% |
| 2011 | $3.97M | -11.0% |
| 2010 | $4.46M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $919.99M | -24.6% | -0.0% |
| September 30, 2025 | $920.39M | -24.5% | -0.0% |
| June 30, 2025 | $920.83M | -24.4% | -0.0% |
| March 31, 2025 | $921.23M | +15.5% | -24.5% |
| December 31, 2024 | $1.22B | +42.4% | +0.0% |
| September 30, 2024 | $1.22B | +62.9% | +0.1% |
| June 30, 2024 | $1.22B | +62.2% | +52.8% |
| March 31, 2024 | $797.56M | +5.8% | -6.9% |
- HAEMONETICS CORP showed an increase of +15.5% in Long-Term Debt compared to the prior fiscal year.
- Over the 2010–2025 period, HAEMONETICS CORP’s long-term debt has grown by 20564.6% (from $4.46 million to $921.23 million).
- The most recent figure is from HAEMONETICS CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: